Results
|
1381.
|
|
|
1382.
|
|
|
1383.
|
SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. [electronic resource] by
- Zhang, Siyuan
- Huang, Wen-Chien
- Zhang, Lin
- Zhang, Chenyu
- Lowery, Frank J
- Ding, Zhaoxi
- Guo, Hua
- Wang, Hai
- Huang, Suyun
- Sahin, Aysegul A
- Aldape, Kenneth D
- Steeg, Patricia S
- Yu, Dihua
Producer: 20131114
In:
Cancer research vol. 73
Availability: No items available.
|
|
1384.
|
|
|
1385.
|
|
|
1386.
|
|
|
1387.
|
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer. [electronic resource] by
- Storniolo, Anna Maria
- Pegram, Mark D
- Overmoyer, Beth
- Silverman, Paula
- Peacock, Nancy W
- Jones, Suzanne F
- Loftiss, Jill
- Arya, Nikita
- Koch, Kevin M
- Paul, Elaine
- Pandite, Lini
- Fleming, Ronald A
- Lebowitz, Peter F
- Ho, Peter T C
- Burris, Howard A
Producer: 20080813
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26
Availability: No items available.
|
|
1388.
|
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice. [electronic resource] by
- Strecker, Tracy E
- Shen, Qiang
- Zhang, Yun
- Hill, Jamal L
- Li, Yuxin
- Wang, Chunyu
- Kim, Hee-Tae
- Gilmer, Tona M
- Sexton, Krystal R
- Hilsenbeck, Susan G
- Osborne, C Kent
- Brown, Powel H
Producer: 20090202
In:
Journal of the National Cancer Institute vol. 101
Availability: No items available.
|
|
1389.
|
A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer. [electronic resource] by
- Sridhar, Srikala S
- Hotte, Sebastien J
- Chin, Joseph L
- Hudes, Gary R
- Gregg, Richard
- Trachtenberg, John
- Wang, Lisa
- Tran-Thanh, Danh
- Pham, Nhu-An
- Tsao, Ming-Sound
- Hedley, David
- Dancey, Janet E
- Moore, Malcolm J
Producer: 20110107
In:
American journal of clinical oncology vol. 33
Availability: No items available.
|
|
1390.
|
Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases. [electronic resource] by
- Cha, Mi Young
- Lee, Kwang-Ok
- Kang, Seok-Jong
- Jung, Young Hee
- Song, Ji Yeon
- Choi, Kyung Jin
- Byun, Joo Yun
- Lee, Han-Jae
- Lee, Gwan Sun
- Park, Seung Bum
- Kim, Maeng Sup
Producer: 20120727
In:
Journal of medicinal chemistry vol. 55
Availability: No items available.
|
|
1391.
|
|
|
1392.
|
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. [electronic resource] by
- Deng, Xinyu
- Li, Qinglin
- Hoff, John
- Novak, Marian
- Yang, Helen
- Jin, Hongyan
- Erfani, Sonia F
- Sharma, Chandan
- Zhou, Pengcheng
- Rabinovitz, Isaac
- Sonnenberg, Arnoud
- Yi, Yajun
- Zhou, Peter
- Stipp, Christopher S
- Kaetzel, David M
- Hemler, Martin E
- Yang, Xiuwei H
Producer: 20130226
In:
Neoplasia (New York, N.Y.) vol. 14
Availability: No items available.
|
|
1393.
|
|
|
1394.
|
|
|
1395.
|
|
|
1396.
|
Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models. [electronic resource] by
- Hou, Wenmin
- Qin, Xia
- Zhu, Xuehua
- Fei, Maogui
- Liu, Ping
- Liu, Li
- Moon, Hanlim
- Zhang, Pingkuan
- Greshock, Joel
- Bachman, Kurtis E
- Ye, Bang-Ce
- Wang, Hui
- Zang, Crystal Ying Qin
Producer: 20140227
In:
Oncology reports vol. 30
Availability: No items available.
|
|
1397.
|
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer. [electronic resource] by
- Korkola, James E
- Collisson, Eric A
- Heiser, Laura
- Oates, Chris
- Bayani, Nora
- Itani, Sleiman
- Esch, Amanda
- Thompson, Wallace
- Griffith, Obi L
- Wang, Nicholas J
- Kuo, Wen-Lin
- Cooper, Brian
- Billig, Jessica
- Ziyad, Safiyyah
- Hung, Jenny L
- Jakkula, Lakshmi
- Feiler, Heidi
- Lu, Yiling
- Mills, Gordon B
- Spellman, Paul T
- Tomlin, Claire
- Mukherjee, Sach
- Gray, Joe W
Producer: 20160427
In:
PloS one vol. 10
Availability: No items available.
|
|
1398.
|
|
|
1399.
|
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in [electronic resource] by
- Gambardella, Valentina
- Gimeno-Valiente, Francisco
- Tarazona, Noelia
- Martinez-Ciarpaglini, Carolina
- Roda, Desamparados
- Fleitas, Tania
- Tolosa, Pablo
- Cejalvo, Juan Miguel
- Huerta, Marisol
- Roselló, Susana
- Castillo, Josefa
- Cervantes, Andrés
Producer: 20200408
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
1400.
|
|